Vaccination

Oxford University Coronavirus Vaccine Reports Promising Early Results

July 20, 2020

Article

The vaccine induced T cell response in about 2 weeks, and antibody response in about 4 weeks, among 1000-plus healthy adults.

A Look at the COVID-19 Demographic Disparity

May 10, 2020

Article

Why the virus is burdening US populations similar to other diseases.

Shingles Vaccine Could Reduce Stroke Risk

February 12, 2020

Article

Older patients with no stroke history are shown to have reduced risk for both shingles and stroke in new CDC data.

FDA Approves New Vaccine for Influenza A (H5N1)

February 03, 2020

Article

Seqirus announced approval of influenza A monovalent vaccine, adjuvanted (Audenz™) for protection against influenza A in a release on Monday morning.

Flu Cases Reach 13 Million in the US, CDC Reports

January 23, 2020

Article

New data for the 2019-2020 season shows the virus is at a high activity, but disease severity is moderate.

Previous Flu Severity, Vaccine Effectiveness, Does Not Affect Vaccination Rates

November 22, 2019

Article

Though vaccination rates are decreasing in children and adolescents overall, it is not due to consideration of previous season's successes or failures.

Q&A with Leonard Calabrese, DO: Vaccinating in Immunocompromised Patients

November 14, 2019

Article

Renowned infectious disease expert Leonard Calabrese, DO, professor of medicine at the Cleveland Clinic Lerner College of Medicine, takes part in a Q&A on vaccinations in immunocompromised patient populations.

Study Suggests Zoster Vaccine Safe in Patients Receiving TNF Inhibitors

November 10, 2019

Article

Jeffrey Curtis, MD, discusses the results of a study he led examining the safety of the zoster vaccine in immunocompromised populations, specifically patienta with rheumatic diseases receiving TNF inhibitors.

Flu Vaccinations Underwhelming Among Hospitalized Pneumonia Patients

October 22, 2019

Article

Fewer than 2% of all patients hospitalized with pneumonia in 2014 received the vaccination.

FDA Approves Baloxavir Marboxil for Flu Complications

October 17, 2019

Article

Xofluza is currently being evaluated in a phase 3 development program for the reduced transmission of flu from an infected person to healthy people.

x